Free Newsletter
Register for our Free Newsletters
Zones
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Materials
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
 
 
 
 
 
 
 
 
News

Sigma-Aldrich launches online web portal for stem cell research product portfolio

Sigma-Aldrich Research Biotech : 12 March, 2009  (Company News)
A new online web portal has been launched by Sigma-Aldrich that provides researchers with immediate access to its portfolio of industry-leading products developed specifically for advanced stem cell research.
The new portal features more than 1,100 highly-focused products that are expected to support every step of the stem cell research workflow - from isolation, characterization, expansion, differentiation and functional profiling to in-vitro/in-vivo tracking. In addition, a team of regenerative medicine experts has been retained to continue to identify and develop new and promising technologies in this growing area. The portal also provides access to a robust stem cell biology community and is available at http://www.sigma-aldrich.com/stemcell 'As a leading destination for life science researchers to access deep biological information and market-leading products, Sigma's focus is to help scientists resolve complex biological questions,' said Dr Dave Smoller, president of the company's Research Biotech business unit. 'Our focus on regenerative medicine and the resulting growing line of stem cell products should help our customers develop cardiac, hematopoietic, endocrine, and neurological disease therapies.' The portal's expanding line of cutting-edge technologies for stem cell research includes the industry's most highly-validated shRNA library, the MISSION RNAi portfolio, which enables gene silencing across a wide range of cellular targets. The site also features the CompoZr zinc finger nuclease (ZFN) reagent platform which enables researchers, for the first time, to target and precisely manipulate the genome of both differentiated cells and stem cells, resulting in cell lines or whole organisms with permanent, targeted gene deletions, insertions, or corrections. A complete line of polyclonal and monoclonal antibodies is available, including the Prestige Antibodies collection, considered the industry's most highly characterised line of antibodies. Stemlin animal serum-free media, essential to many researchers in the expansion and maturation of cell lines, is also available.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com